UK markets closed

PURE Bioscience, Inc. (PURE)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0700-0.0090 (-11.39%)
At close: 03:07PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/07/2023
31/07/2022
31/07/2021
31/07/2020
Total revenue
2,057
1,877
1,853
3,927
6,917
Cost of revenue
921
906
853
1,852
2,896
Gross profit
1,136
971
1,000
2,075
4,021
Operating expenses
Research development
300
297
319
339
322
Selling general and administrative
4,095
4,302
4,051
4,047
3,695
Total operating expenses
4,395
4,599
4,370
4,386
4,017
Operating income or loss
-3,259
-3,628
-3,370
-2,311
4
Interest expense
72
14
6
4
5
Total other income/expenses net
-
-319
-115
-4
5
Income before tax
-3,645
-3,961
-3,491
-2,319
4
Income from continuing operations
-3,645
-3,961
-3,491
-2,319
4
Net income
-3,645
-3,961
-3,491
-2,319
4
Net income available to common shareholders
-3,645
-3,961
-3,491
-2,319
4
Basic EPS
-0.04
-0.04
-0.04
-0.03
0.00
Diluted EPS
-0.04
-0.04
-0.04
-0.03
0.00
Basic average shares
111,529
111,404
88,835
87,174
82,209
Diluted average shares
111,529
111,404
88,835
87,174
84,612